Help-seeking patterns and funding strategies in patients with pulmonary arterial hypertension on phosphodiesterase-5 inhibitors: an orphan disease with effective but costly treatment.

CONCLUSION: Fewer than expected patients were found to be receiving drug subsidies for PAH. This was partly due to insufficient referrals and lack of requests for financial assistance. Patients on combination therapy had greater financial challenges. This study should spur us on to study funding gaps further and address them.
PMID: 32179923 [PubMed - as supplied by publisher]

Source: Singapore Medical Journal - March 16, 2020 Category: General Medicine Authors: Lim Y, Maaroof SMB, Low TT, Kuntjoro I, Yip JW, Tay E Tags: Singapore Med J Source Type: research